S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial
Pre-publication versions of this article are available by contacting email@example.com.
|26 Jul 2013||Submitted||Original manuscript|
|13 Oct 2013||Reviewed||Reviewer Report - In Hae Park|
|14 Oct 2013||Reviewed||Reviewer Report - Rami Haddad|
|3 Nov 2013||Author responded||Author comments - Yong Wha Moon|
|Resubmission - Version 2|
|3 Nov 2013||Submitted||Manuscript version 2|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|14 Nov 2013||Author responded||Author comments - Yong Wha Moon|
|Resubmission - Version 4|
|14 Nov 2013||Submitted||Manuscript version 4|
|2 Dec 2013||Editorially accepted|
|6 Dec 2013||Article published||10.1186/1471-2407-13-583|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.